Hydroxypropylmethylcellulose gel application delays Der p 1 diffusion in vitro

HTML  Download Download as PDF (Size: 526KB)  PP. 79-84  
DOI: 10.4236/ns.2010.22012    6,929 Downloads   12,827 Views  Citations

Affiliation(s)

.

ABSTRACT

Background: A special hydroxypropylmethyl-cellulose powder (Nasaleze?) has been used for the alleviation of nasal symptoms of allergic rhinitis since 1994. The efficacy of the product has been recently proven but the mechanism of action was still largely unknown. The aim of the study was to investigate the hypothesis that the gel formed after moisture absorption in the nose might act as mechanical barrier that prevents allergen diffusion towards the nasal epithelium. Methods: The diffusion of Der p 1 through HPMC and agar gels was measured in vitro after 15, 30, 60, 180 and 360 minutes using ELISA. Agar blocks were used to simulate the nasal mucosa. Control samples without gel layer were obtained. Results: The control samples with no applied gel barrier absorbed 72.2 % of the Der p 1 solution after 15 minutes and 100 % after 60 minutes. In comparison, the HPMC and agar gel layers both significantly delayed Der p 1 diffu-sion. After 15 minutes 0.76 % had diffused through the HPMC gel layer compared to 28.1 % which diffused through the agar layer. After 360 minutes, 14.1 % of the baseline Der p 1 crossed the HPMC gel layer while 100 % had diffused through the agar layer. Conclusions: HPMC gel significantly reduces Der p 1 diffusion in vitro compared to no barrier and an agar gel layer. This is likely to be due to the small mesh size of the polymer network of HPMC and could have important implications for a preventative treat-ment of allergic rhinitis.

Share and Cite:

Diethart, B. , Emberlin, J. and Lewis, R. (2010) Hydroxypropylmethylcellulose gel application delays Der p 1 diffusion in vitro. Natural Science, 2, 79-84. doi: 10.4236/ns.2010.22012.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.